FUJIFILM Toyama

What FUJIFILM Toyama does

FUJIFILM Toyama Chemical Co., Ltd. is a wholly-owned subsidiary of FUJIFILM Holdings Corporation (TSE: 4901), established in October 2018 through the integration of FUJIFILM RI Pharma Co., Ltd., TOYAMA CHEMICAL CO., LTD., and Cellular Dynamics International Japan Co., Ltd. The subsidiary specializes in pharmaceuticals, regenerative medicine, and life sciences products, operating within the broader Fujifilm Group's Healthcare segment. The group's pharmaceutical and biopharmaceutical operations are anchored by FUJIFILM Diosynth Biotechnologies (biologics CDMO, consolidated April 2022) and FUJIFILM Irvine Scientific (cell culture media and life sciences, consolidated June 2018 and now FUJIFILM Biosciences), positioning the Toyama Chemical entity within Fujifilm's strategy to build a vertically integrated biopharma value chain.

The broader Fujifilm Group, of which FUJIFILM Toyama is a part, operates four business segments: Healthcare (medical imaging systems, endoscopy, in-vitro diagnostics, bio CDMO, pharmaceuticals, regenerative medicine), Electronics (semiconductor process materials, flat panel display materials, recording media, optical devices, electronic materials), Business Innovation (ApeosPort multifunction devices, Revoria production color printers, DocuWorks document software, FUJIFILM IWpro cloud service), and Imaging (INSTAX instant cameras, digital cameras, photographic film, color paper, photofinishing). The portfolio includes the ECHELON Smart ZeroHelium 1.5 tesla MRI system, FUJINON broadcast and optical products, and a connected INSTAX ecosystem with dedicated mobile apps. Group revenue of 3,357.0 billion yen and 73,526 employees as of March 2026 support a global footprint spanning North America, Europe, Latin America, the Middle East, Africa, Asia, and Oceania.

The group generates revenue through a mix of hardware sales (Healthcare, Electronics, Imaging), subscription and recurring revenue (Business Innovation consumables, services, and cloud subscriptions including FUJIFILM IWpro), and biopharmaceutical CDMO services. Go-to-market is executed via direct enterprise field sales for healthcare and electronics materials, authorized channel partners and resellers for Business Innovation document solutions, and global retail and distribution networks for consumer imaging products. FUJIFILM Toyama Chemical specifically contributes to the pharmaceutical and regenerative medicine value chain, leveraging the group's proprietary colloidal chemistry, optical engineering, and thin film coating technology platforms originally developed for photographic film and now applied across healthcare, electronics, and life sciences.

Name

FUJIFILM Toyama

Legal name

FUJIFILM Holdings Corporation

Website

https://fujifilm.com

Company type

Public

Founded year

1934

Operating status

Operating

Short description

FUJIFILM Toyama Chemical Co., Ltd. is a wholly-owned subsidiary of FUJIFILM Holdings that develops pharmaceuticals, regenerative medicine, and life sciences products within the Fujifilm Group's healthcare and biopharmaceutical CDMO portfolio.

Ownership category

akta.pro rank

Product category

Healthcare and Medical Imaging

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

X-ray & Fluoroscopy Systems (HLAHABAA)

akta.pro secondary industry

Viral Vector Manufacturing Services (AAV, lentiviral, adenoviral) (HLAAAKAD)

Keywords

• Medical imaging equipment
• Pharmaceutical products
• Instant cameras
• Document solutions
• Semiconductor materials

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Healthcare: Medical systems (X-ray, CT, MRI, ultrasound, endoscopy), in-vitro diagnostics, regenerative medicine, bio CDMO, pharmaceuticals, cell culture media, and life sciences solutions.
2. Electronics: Semiconductor process materials, display materials (TV, smartphone, automotive), recording media (data storage tapes), optical devices (lenses), electronic materials.
3. Business Innovation: Office multifunction devices, printers, production print systems, services and support, paper, consumables, office services.
4. Imaging: Instant cameras (INSTAX), digital cameras, photographic film, color paper, photofinishing equipment, photo services and apps.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

FUJIFILM Toyama, as part of the Fujifilm Group, provides total healthcare solutions spanning prevention, diagnosis, and treatment, including medical imaging systems, endoscopy, in-vitro diagnostics, pharmaceuticals, and regenerative medicine products. The broader group also supplies semiconductor and display materials, office document solutions and multifunction devices, and consumer imaging products such as INSTAX instant cameras and photofinishing services.

Product overview

FUJIFILM Toyama operates as part of the Fujifilm Group, offering products and services across Healthcare, Electronics, Business Innovation, and Imaging business segments. The Imaging Solutions business includes INSTAX instant cameras and printers (INSTAX Pal, INSTAX mini Evo, INSTAX mini LiPlay, INSTAX mini Link, INSTAX Link WIDE, INSTAX SQUARE Link, INSTAX mini 99), digital cameras operated via FUJIFILM Camera Remote app, and consumer mobile apps for photo printing and photobook creation (Smart Photo Ordering App, FUJIFILM Year Album, FUJIFILM Photobook). Healthcare offerings include SYNAPSE Erm teleradiology imaging software and ECHELON Smart ZeroHelium MRI system. The Business Innovation segment provides multifunction devices under the ApeosPort and Apeos brands, production color printers under Revoria, DocuWorks document software, and FUJIFILM IWpro cloud service with AI chat functionality. Optical devices include FUJINON binoculars and broadcast zoom lenses. The portfolio includes 23 Red Dot Design award winners and 26 iF Design Award 2024 winners.

Differentiator

Problem solved

Functional benefit

Brands

• instax: Instant camera and photo printer brand including instax mini, instax SQUARE, and instax WIDE product lines
• SYNAPSE
• ApeosPort
• DocuWorks

Products and services

• ECHELON Smart ZeroHelium MRI System 1.5T superconductive magnet MRI system for diagnostic imaging that operates without liquid helium, reducing infrastructure and maintenance requirements for hospitals and imaging centers.
• SYNAPSE Erm Teleradiology imaging support system for emergency rooms, designed for healthcare professionals to access and share diagnostic images.
• INSTAX Pal Compact digital camera with a dedicated Bluetooth app for remote shooting and image transfer to smartphones.
• INSTAX mini Evo Hybrid instant camera with app connectivity for remote shooting and smartphone printing onto INSTAX MINI film.
• INSTAX mini LiPlay Hybrid instant camera with Bluetooth connectivity for remote operation and smartphone printing.
• INSTAX mini 99 Analog instant camera in the INSTAX mini line, recognized with the IDEA Bronze Award for design.
• INSTAX SQUARE Link Smartphone printer that connects via Bluetooth to print photos and video stills onto INSTAX SQUARE film.
• INSTAX Link WIDE Smartphone printer that connects via Bluetooth to print photos onto INSTAX WIDE film.
• INSTAX mini Link Compact smartphone printer with Bluetooth connectivity featuring Frame Print, Video Print, and Party Print functions.
• INSTAX SHARE SP-2
• ApeosPort Multifunction Devices Brand of multifunction devices for office document solutions, including the Apeos C5570 model which complies with EPEAT 2.0 environmental criteria.
• Revoria Production Color Printers Production color printer brand offering high-value print systems for commercial print providers, supported by the Revoria Experience Center for validation and training.
• DocuWorks Document Software Document workflow software for managing, processing, and archiving office documents across the enterprise.
• FUJIFILM IWpro Cloud Service Cloud-based document workflow management service with an AI chat function that uses natural language processing to automate and streamline office document processes.
• Xerox FreeFlow Core Print workflow automation software supporting production print environments, with ongoing security vulnerability management.
• FUJINON BINOCULAR TECHNO-STABI TS-L 1640/2040 Image-stabilized binoculars serving professional and enthusiast observation use cases; recognized with the IDEA Gold Award.
• FUJINON HZK14-100mm Broadcast Zoom Lens Broadcast zoom lens for professional video production; recognized with the IDEA Bronze Award.

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration17 records

AI capability2 records

Feature4 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Global Procurement Partners Corp.coreStrategic or Co-development Partner · 1 January 2025Joint venture between FUJIFILM Business Innovation Corp. and Konica Minolta, Inc. established in January 2025 for global procurement optimization.
• Entegris, Inc.coreTechnology or Integration · 1 October 2023Acquisition of Electronic Chemicals Business from Entegris, Inc. completed in October 2023, strengthening semiconductor materials portfolio.
• Hitachi, Ltd.coreTechnology or Integration · 1 March 2021Acquisition of Diagnostic Imaging-related Business from Hitachi, Ltd. completed in March 2021, establishing Fujifilm Healthcare Corporation for medical systems operations.
• FUJIFILM RIPCORDcoreStrategic or Co-development Partner · 1 September 2020Joint venture between Fuji Xerox (now FUJIFILM Business Innovation) and Ripcord to provide services that drive digital transformation (DX) for enterprises.
• BiogencoreTechnology or Integration · 1 August 2019Biogen (Denmark) Manufacturing ApS became a consolidated subsidiary of FUJIFILM Corporation in August 2019, expanding biopharmaceutical manufacturing capabilities.
• FUJIFILM Toyama Chemical Co., Ltd.coreOthers · 1 October 2018Established October 2018 through integration of FUJIFILM RI Pharma Co., Ltd., TOYAMA CHEMICAL CO., LTD. and Cellular Dynamics International Japan Co.,Ltd. Specializes in pharmaceuticals and regenerative medicine.
• Fujifilm Kyowa Kirin BiologicscoreStrategic or Co-development Partner · 1 March 2012Joint venture established in March 2012 for the development, manufacturing and sales of biosimilars, combining Fujifilm's manufacturing technologies with Kyowa Hakko Kirin's biopharmaceutical expertise.
• UN Global CompactminorOthersFujifilm Holdings participates in the UN Global Compact, committing to universal sustainability principles.
• Japan Business Federation (Keidanren)minorOthersFujifilm Holdings is a member of the Japan Business Federation, a major business organization in Japan.
• Japan Electronics and Information Technology Industries Association (JEITA)minorOthersFujifilm Holdings participates in JEITA for electronics and IT industry policy and standards.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• GE HealthCare: Direct competitor in medical imaging (CT, MRI, ultrasound, X-ray) and healthcare IT. Comparable because both target the same hospital radiology and cardiology customers with overlapping modality portfolios after FUJIFILM's acquisition of Hitachi's diagnostic imaging business.
• Konica Minolta: Closest Japanese comparable across business innovation (office multifunction devices, production print), healthcare (digital radiography), and specialty materials. Comparable because the segment mix and customer base overlap heavily with FUJIFILM Business Innovation and Healthcare.
• Hologic: Medical imaging and diagnostics peer focused on women's health, mammography, and surgical imaging. Comparable because Hologic competes in specialty diagnostic imaging modalities sold to hospitals and clinics, mirroring FUJIFILM's imaging-and-IVD go-to-market.
• Koninklijke Philips: Healthcare technology and medical imaging peer. Comparable because both compete in diagnostic imaging, patient monitoring, and connected care solutions sold to hospitals and health systems across global markets.
• Siemens Healthineers: Global medical imaging and diagnostics peer. Comparable as both companies offer integrated imaging systems (CT, MRI, X-ray) plus IVD and enterprise services to the same hospital and clinic customer base worldwide.
• Ricoh Company: Direct peer in office document solutions, managed print services, and production print. Comparable because Ricoh sells into the same enterprise office channel as FUJIFILM Business Innovation and is undergoing a similar shift from hardware to services-led recurring revenue.

Emerging players

• Lonza Group: Global biologics contract development and manufacturing organization (CDMO). Comparable because Lonza is a primary competitor to FUJIFILM Diosynth Biotechnologies in outsourced mammalian cell culture, viral vector, and biologics manufacturing services.

Broad incumbents

• Canon Inc. Broad incumbent spanning cameras, medical imaging (Canon Medical Systems), office document solutions, and semiconductor lithography equipment. Comparable because Canon operates across the same four pillars as FUJIFILM (Healthcare, Electronics materials exposure, Business Innovation, Imaging).
• Shin-Etsu Chemical: Japanese semiconductor materials and silicon wafer incumbent. Comparable because Shin-Etsu supplies photoresists, silicon wafers, and rare-earth materials to the same fab customers FUJIFILM targets in its Electronics segment, defining the competitive set for materials share.
• Sony Group Corporation: Imaging peer across consumer cameras, sensors, and medical/professional imaging. Comparable because both companies leverage heritage in optical and imaging technology into medical, professional, and consumer imaging product lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/FUJIFILMBusinessInnovation
• LinkedInlinkedin.com/company/fujifilmcorporation

Compliance31 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FUJIFILM Toyama